Research and Innovation Data Summary 2005-2008
|
|
2008
|
2007
|
2006
|
2005
|
|
Filed U.S. patent applications
|
216
|
200
|
227
|
227
|
|
Initiated licenses for new technologies1
|
46
|
55
|
53
|
122
|
1 Includes acquisitions, research collaborations, and preclinical and clinical compounds.
Patents
In 2008, Merck filed 216 original U.S. patent applications. The number of U.S. patents granted during that same period was 146. Many of these patents were related to compounds in various stages of development. The number of filings and patents granted demonstrates the extent of innovation taking place at Merck Research Laboratories.
The content on this page was last modified on September 15, 2009.
Merck & Co., Inc., Whitehouse Station, NJ, USA, and Schering-Plough Corporation, Kenilworth, NJ, USA, are now one company. We have combined our global operations under the name Merck & Co., Inc. We are working to update our corporate responsibility Web site to reflect our new, combined, global organization.
Printer Friendly Page